Solutions

One platform. Configured for how your trials run.

Bioequivalence, generics development, multi-therapy CRO operations, sponsor programs, and academic research — on the same data model and audit trail.

By who you are

Built for CROs, end to end.

Bioequivalence (BA-BE) specialists

Replicate designs and intensive PK sampling, without a second system. Pre-built templates, volunteer randomization tied to dispensing, and ANDA-ready exports from the same data model.

Learn more

Generic-drug CROs

Short, focused trials, run at volume. Repeat protocol designs set up in days, priced per study or per month, with the whole portfolio on one data model.

Learn more

Multi-therapy CROs

Phase II to IV across therapeutic areas, on one data model. Configurable workflows and a single continuous audit trail, whatever the indication.

Learn more

Global CRO networks

Sponsor-grade quality without disrupting the tooling your global team already runs. Local submission support where the study needs it.

Learn more

Biotech & pharma sponsors

Own your trial data end to end. DPDP Act 2023 aligned, with in-jurisdiction contracting and no vendor holding the master copy.

Learn more

Academic & government trial groups

Grant-funded research without enterprise-CRO overhead. Stand a study up on a research budget and keep the audit trail a regulator expects.

Learn more

By phase

From BA-BE bioequivalence to post-marketing.

By phase — BA-BE through IV

From bioequivalence studies and first-in-human dose escalation to post-marketing surveillance. The same schema carries the study through every phase.

Learn more

By therapy area

Configured to your protocol.

By therapy area

Oncology, cardiology, infectious disease, rare disease and devices. Visit schedules and instrument libraries configured to your protocol.

Learn more

Built for every role

One platform that works the way each team does.

Sponsors, CROs, data managers, investigators, coordinators, and PV — one login, tailored to the job.

Sponsor ClinOps

See what needs attention, not what has already happened. Overdue visits, aging queries and lock readiness, without asking for a status deck.

app.trialion.com

Queries aging past 14 days

Visits overdue across 3 sites

Studies ready for database lock

StudyDesignStageNext date

TRL-204Phase IIIIn UATGo-live 14 Mar

TRL-118BA-BEEnrolling3 sites behindLock 02 Apr

TRL-091Phase IIData cleaningLock 21 Mar

TRL-077Phase IVLiveLock 30 Jun

Portfolio — what needs attention this week